137 related articles for article (PubMed ID: 28624749)
1. Prevalence and clinical significance of incidental extra-mammary findings in breast magnetic resonance imaging: A retrospective study of 1070 patients.
Staab W; Menke J; Sohns C; Wienbeck S; Bauer L; Kowallick JT; Konietschke F; Derlin T; Lotz J; Sohns JM
Clin Imaging; 2017; 45():92-95. PubMed ID: 28624749
[TBL] [Abstract][Full Text] [Related]
2. Screening breast MR imaging: comparison of interpretation of baseline and annual follow-up studies.
Abramovici G; Mainiero MB
Radiology; 2011 Apr; 259(1):85-91. PubMed ID: 21285337
[TBL] [Abstract][Full Text] [Related]
3. Contrast-enhanced MR mammography for evaluation of the contralateral breast in patients with diagnosed unilateral breast cancer or high-risk lesions.
Pediconi F; Catalano C; Roselli A; Padula S; Altomari F; Moriconi E; Pronio AM; Kirchin MA; Passariello R
Radiology; 2007 Jun; 243(3):670-80. PubMed ID: 17446524
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and Predictive Value of BI-RADS 3, 4, and 5 Lesions Detected on Breast MRI: Correlation with Study Indication.
Chikarmane SA; Tai R; Meyer JE; Giess CS
Acad Radiol; 2017 Apr; 24(4):435-441. PubMed ID: 27955878
[TBL] [Abstract][Full Text] [Related]
5. Dynamic contrast-enhanced MR imaging in screening detected microcalcification lesions of the breast: is there any value?
Uematsu T; Yuen S; Kasami M; Uchida Y
Breast Cancer Res Treat; 2007 Jul; 103(3):269-81. PubMed ID: 17063274
[TBL] [Abstract][Full Text] [Related]
6. Contrast-enhanced MR imaging in patients with BI-RADS 3-5 microcalcifications.
Cilotti A; Iacconi C; Marini C; Moretti M; Mazzotta D; Traino C; Naccarato AG; Piagneri V; Giaconi C; Bevilacqua G; Bartolozzi C
Radiol Med; 2007 Mar; 112(2):272-86. PubMed ID: 17361370
[TBL] [Abstract][Full Text] [Related]
7. Characteristics, Malignancy Rate, and Follow-up of BI-RADS Category 3 Lesions Identified at Breast MR Imaging: Implications for MR Image Interpretation and Management.
Chikarmane SA; Birdwell RL; Poole PS; Sippo DA; Giess CS
Radiology; 2016 Sep; 280(3):707-15. PubMed ID: 27089027
[TBL] [Abstract][Full Text] [Related]
8. Focal Breast Lesions in Clinical CT Examinations of the Chest: A Retrospective Analysis.
Krug KB; Houbois C; Grinstein O; Borggrefe J; Puesken M; Hanstein B; Malter W; Maintz D; Hellmich M
Rofo; 2017 Oct; 189(10):977-989. PubMed ID: 28683503
[No Abstract] [Full Text] [Related]
9. Nonmasslike enhancement at breast MR imaging: the added value of mammography and US for lesion categorization.
Thomassin-Naggara I; Trop I; Chopier J; David J; Lalonde L; Darai E; Rouzier R; Uzan S
Radiology; 2011 Oct; 261(1):69-79. PubMed ID: 21771958
[TBL] [Abstract][Full Text] [Related]
10. Assessment of BI-RADS category 4 lesions detected with screening mammography and screening US: utility of MR imaging.
Strobel K; Schrading S; Hansen NL; Barabasch A; Kuhl CK
Radiology; 2015 Feb; 274(2):343-51. PubMed ID: 25271857
[TBL] [Abstract][Full Text] [Related]
11. Breast imaging reporting and data system (BI-RADS) lexicon for breast MRI: interobserver variability in the description and assignment of BI-RADS category.
El Khoury M; Lalonde L; David J; Labelle M; Mesurolle B; Trop I
Eur J Radiol; 2015 Jan; 84(1):71-76. PubMed ID: 25454100
[TBL] [Abstract][Full Text] [Related]
12. Role of combined BI-RADS assessment using mammography and sonography for evaluation of incidental hypermetabolic lesions in the breast on 18F-FDG PET-CT.
Lim S; Lee EH; Park JM; Chang YW; Kim HH; Jeong SH
Acta Radiol; 2013 Dec; 54(10):1117-24. PubMed ID: 23864064
[TBL] [Abstract][Full Text] [Related]
13. MR imaging in probably benign lesions (BI-RADS category 3) of the breast.
Gökalp G; Topal U
Eur J Radiol; 2006 Mar; 57(3):436-44. PubMed ID: 16316732
[TBL] [Abstract][Full Text] [Related]
14. Role of second-look ultrasound examinations for MR-detected lesions in patients with breast cancer.
Lee SH; Kim SM; Jang M; Yun BL; Kang E; Kim SW; Park SY; Ahn HS; Chang JH; Yoo Y; Song TK; Moon WK
Ultraschall Med; 2015 Apr; 36(2):140-8. PubMed ID: 25750138
[TBL] [Abstract][Full Text] [Related]
15. [Use of BI-RADS to interpret magnetic resonance mammography for breast cancer].
Kharuzhyk SA; Shimanets SV; Karman AV; Shapoval EV
Vestn Rentgenol Radiol; 2014; (4):46-59. PubMed ID: 25775888
[TBL] [Abstract][Full Text] [Related]
16. Concordance of BI-RADS Assessments and Management Recommendations for Breast MRI in Community Practice.
Lee AY; Ichikawa L; Lee JM; Lee CI; DeMartini WB; Joe BN; Wernli KJ; Sprague BL; Herschorn SD; Lehman CD
AJR Am J Roentgenol; 2016 Jan; 206(1):211-6. PubMed ID: 26700354
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal measurement of clinical mammographic breast density to improve estimation of breast cancer risk.
Kerlikowske K; Ichikawa L; Miglioretti DL; Buist DS; Vacek PM; Smith-Bindman R; Yankaskas B; Carney PA; Ballard-Barbash R;
J Natl Cancer Inst; 2007 Mar; 99(5):386-95. PubMed ID: 17341730
[TBL] [Abstract][Full Text] [Related]
18. Results of MR imaging screening for breast cancer in high-risk patients with lobular carcinoma in situ.
Friedlander LC; Roth SO; Gavenonis SC
Radiology; 2011 Nov; 261(2):421-7. PubMed ID: 21900618
[TBL] [Abstract][Full Text] [Related]
19. Predictive value for malignancy of suspicious breast masses of BI-RADS categories 4 and 5 using ultrasound elastography and MR diffusion-weighted imaging.
Satake H; Nishio A; Ikeda M; Ishigaki S; Shimamoto K; Hirano M; Naganawa S
AJR Am J Roentgenol; 2011 Jan; 196(1):202-9. PubMed ID: 21178068
[TBL] [Abstract][Full Text] [Related]
20. Tailored breast cancer screening program with microdose mammography, US, and MR Imaging: short-term results of a pilot study in 40-49-year-old women.
Venturini E; Losio C; Panizza P; Rodighiero MG; Fedele I; Tacchini S; Schiani E; Ravelli S; Cristel G; Panzeri MM; De Cobelli F; Del Maschio A
Radiology; 2013 Aug; 268(2):347-55. PubMed ID: 23579052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]